Welcome to our dedicated page for AlphaTON Capital SEC filings (Ticker: ATON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AlphaTON Capital Corp (NASDAQ: ATON) files as a foreign private issuer under the Securities Exchange Act of 1934, and its SEC filings provide detailed insight into the company’s digital asset treasury strategy, financing arrangements, governance, and operational priorities. As an issuer incorporated in the British Virgin Islands, AlphaTON submits annual reports on Form 20-F and frequent current reports on Form 6-K.
On this page, users can review AlphaTON’s Form 6-K filings, which have covered topics such as treasury management agreements related to its TON-focused strategy, loan arrangements secured by TON collateral, private placements, at-the-market offering agreements, registered direct offerings, and management changes. These reports also incorporate unaudited condensed consolidated interim financial statements and management’s discussion and analysis for specified periods, as indicated in the exhibits to recent 6-Ks.
AlphaTON’s shelf registration statements on Form F-3 and registration statements on Form S-8 are referenced in multiple 6-Ks, where the company notes that specific reports and exhibits are incorporated by reference into those registration statements. Filings describe how capital raised under these programs may support the company’s activities in digital asset treasury management, AI infrastructure deployments, and broader corporate purposes.
Investors examining AlphaTON’s SEC filings can also find disclosures about agreements with external partners for treasury management, locked asset arrangements, and master loan agreements, as well as clarifications and corrections to prior press releases. Management changes and related contractor agreements are likewise documented in detail.
Stock Titan’s filings page surfaces these documents as they are furnished to EDGAR and can pair them with AI-powered summaries that highlight key terms, risk factors, capital structure implications, and operational updates. Users can quickly locate AlphaTON’s 6-Ks, 20-F references, and other incorporated documents, and can also review insider-related information when Form 4 or similar ownership reports are available, with AI explanations that help interpret complex regulatory language.
AlphaTON Capital Corp registers 481,581 Ordinary Shares underlying Warrants in a prospectus supplement dated March 20, 2026.
The company entered into a sale and purchase agreement to acquire a 60% controlling interest in GaMee Global and certain digital tokens. Completion consideration is $3,500,000 ($1,500,000 cash and $2,000,000 in equity at $1.00 per share), comprising 99,800 Ordinary Shares and Pre‑Funded Warrants exercisable for 1,900,200 Ordinary Shares. Two earn-out tranches together can pay up to $7.5M tied to GaMee EBITDA thresholds of $1.2M and $1.6M.
The agreements include a five‑year strategic alliance, a two‑year standstill, shareholder governance provisions for GaMee Global, and a requirement that the Company purchase $2.0M in GaMee tokens within 90 days of closing. Share issuance to Animoca Brands and token transfers rely on exemptions from registration.
AlphaTON Capital Corp agreed to acquire a 60% controlling interest in Ga Mee Global Limited from Animoca Brands, paying $3.5 million upfront, split between $1.5 million in cash and $2.0 million in equity priced at $1.00 per share via ordinary shares and pre-funded warrants. Animoca Brands can earn up to an additional $7.5 million through two earn-out periods, tied to GaMee’s EBITDA targets of $1.2 million and $1.6 million, paid in fixed cash/equity mixes if thresholds are met.
The company must also purchase $2.0 million of GaMee tokens within 90 days of closing and will sign a shareholders agreement giving it two of three GaMee Global board seats while preserving key reserved matters for Animoca Brands. A five‑year strategic alliance will support GMEE, TON and WAT token ecosystems, and a two‑year standstill restricts Animoca Brands and Yat Siu from control‑seeking actions in AlphaTON. Ga Mee Global’s 2024 audited statements show revenue of $3,183,020, a net loss of $440,157, net liabilities of $4,589,482, and a material going concern uncertainty mitigated by support from its holding company.
AlphaTON Capital Corp filed an initial ownership report for Chief Financial Officer Wesley Allen Levitt. This Form 3 establishes his status as an insider for regulatory reporting purposes. The filing does not list any share transactions or existing derivative positions in the disclosed data.
AlphaTON Capital Corp has received a notice from the Nasdaq Listing Qualifications Department stating that its common stock no longer meets the Nasdaq Capital Market’s minimum bid price requirement of $1.00 per share, after trading below this level for 30 consecutive business days.
The company has a 180-day compliance period, until August 31, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days. If it qualifies, AlphaTON may receive an additional 180 days; otherwise, its shares could become subject to delisting, with the option to appeal to a Nasdaq Hearings Panel.
AlphaTON Capital Corp entered a binding call option agreement granting Immunova the right to acquire iOx Therapeutics, its wholly owned biotech subsidiary focused on liposomal iNKT agonists. If Immunova exercises the option and the acquisition closes, AlphaTON would receive an upfront cash payment, equity equal to 10% of the fully diluted acquiring entity, potential milestone payments that could exceed $100 million, and single-digit royalties on future net sales.
iOx’s lead drug candidate, PORT-2 (IMM60), has Phase 1/2 data in advanced melanoma and metastatic NSCLC showing it was well tolerated with biomarker evidence of immune activation and early signs of anti-tumor activity. Management frames the structure as a way to unlock value from this legacy biotech asset while retaining meaningful long-term economic participation, allowing AlphaTON to prioritize its Telegram-focused technology strategy and other biotech programs. The call option is subject to conditions, including Immunova securing financing, and there is no assurance it will be exercised or that the transaction will close.
AlphaTON Capital Corp signed and closed a $30 million AI compute infrastructure lease to add 504 NVIDIA Blackwell B200 GPUs in Canada. The company expects this deployment to generate a minimum of $1.2 million in monthly revenue starting in March 2026 through hourly rentals to AI developers, enterprises, and the Telegram ecosystem.
At illustrative pricing of $4 per chip per hour, AlphaTON estimates about $1.45 million in monthly revenue from the 504 chips, and projects about $3.11 million per month once a total of 1,080 B200 and B300 chips are online by April 2026. Management cites a 1.7x return multiple and 40% IRR for this lease, positioning the deployment within a broader strategy to scale privacy-centric AI infrastructure for Telegram’s roughly 1 billion users.
AlphaTON Capital Corp established an at-the-market share offering program allowing it to sell up to $400,000,000 of its ordinary shares through H.C. Wainwright & Co. as sales agent or principal. Sales will be made under an effective Form F-3 shelf and a new prospectus supplement, with commissions of up to 3.0% of gross proceeds.
The company plans to use any net proceeds to fund capital spending for development, training and operation of its Cocoon AI platform, including servers, GPUs and related infrastructure, to pursue complementary acquisitions or investments, and for working capital and other general corporate purposes.
AlphaTON Capital Corp is launching an at-the-market equity program to sell up to $400,000,000 of ordinary shares through H.C. Wainwright as sales agent or principal. Shares may be sold from time to time on Nasdaq under the symbol ATON or through other permitted methods at prevailing market prices.
The company plans to use net proceeds mainly to fund capital expenditures for Cocoon AI, including servers, GPUs and related infrastructure, and to pursue strategic acquisitions or investments aligned with the Telegram and TON ecosystem, with any remainder for working capital and general corporate purposes.
As context, AlphaTON reports 23,434,588 ordinary shares outstanding as of February 13, 2026, so issuing a large portion of the program would significantly increase the share count and dilute existing holders. Wainwright will receive up to a 3.0% sales commission on gross proceeds.
AlphaTON Capital Corp entered into a termination, rescission and transfer agreement with Compedica Holdings Limited to unwind a prior share-for-share exchange. The June 2025 deal had swapped 625,000 AlphaTON ordinary shares at $8.00 per share for 1,165,501 Compedica shares at $4.29 per share.
Under the new agreement, each party returned the shares it had received, with no additional consideration paid. The agreement includes customary representations, warranties, mutual indemnities and broad mutual releases of claims related to the original exchange.
AlphaTON Capital Corp maintains its registration of 481,581 Ordinary Shares underlying warrants and issues a prospectus supplement that incorporates new corporate information. The supplement attaches a Form 6-K reporting that director Steven Mintz resigned effective February 6, 2026, and that F. Daniel Siciliano was unanimously appointed to the board the same day. The company notes its Ordinary Shares trade on Nasdaq under the symbol ATON, with a February 5, 2026 closing price of $0.4927.